Stocks making the biggest moves midday: Merck, Bristol-Myers Squibb, Align Technology and more

  • 📰 CNBC
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 72%

Ireland News News

Ireland Ireland Latest News,Ireland Ireland Headlines

These are the stocks posting the largest moves in midday trading.

Check out the companies making headlines in midday trading. Bunge — Shares of the global crop trader and processor popped 5.2% after the company lifted its 2023 outlook and reported better-than-expected profit for the third quarter. Bunge's earnings were lower year-on-year, however. Comcast — Comcast shares fell 6.3% after the telecom giant reported a loss in high-speed broadband subscribers. Advertising revenue from NBCUniversal was also weak.

Align Technology — The medical device maker dropped 25% on Thursday after missing Wall Street forecasts in the third quarter and offering weak guidance for current-quarter revenue. Align posted $2.14 in earnings per share excluding items and $960 million in revenue in the third quarter. Analysts polled by LSEG expected earnings of $2.26 per share and revenue at $995 million. American Tower Corporation — The American real estate investment trust added 8.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 12. in İE
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Ireland Ireland Latest News, Ireland Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bristol-Myers Squibb earnings top estimatesCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Source: MarketWatch - 🏆 3. / 97 Read more »

Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competitionBristol Myers Squibb’s revenue was in line with estimates, but fell slightly from the same period last year due to lower sales of blood cancer drug Revlimid.
Source: CNBC - 🏆 12. / 72 Read more »

Japanese stocks rise for second session as Hong Kong stocks gainSupported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy.
Source: MarketWatch - 🏆 3. / 97 Read more »